[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345697-105":59,"doc-detail-345697-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","higher-order-multiple-primary-cancers-and-persistent-cross-site-risk-across-human-papillomavirus-related-anatomical-sites-in-the-united-states-objective-methods-results-and-conclusions","Higher-order multiple primary cancers and persistent cross-site risk across human papillomavirus-related anatomical sites in the United States - Objective, Methods, Results and Conclusions","","Survivors of cancers at human papillomavirus (HPV)-related sites face elevated risk of additional malignancies, yet the overall burden, detailed distribution, and long-term cross-site risk patterns of higher-order (≥3 primaries) multiple primary cancers (MPCs) are not well defined. This population-based retrospective cohort study uses US SEER registries to quantify MPC incidence, latency-specific risks, and bidirectional cross-site associations, informing prevention and early detection strategies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/higher-order-multiple-primary-cancers-and-persistent-cross-site-risk-across-human-papillomavirus-related-anatomical-sites-in-the-united-states-objective-methods-results-and-conclusions/345697/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/higher-order-multiple-primary-cancers-and-persistent-cross-site-risk-across-human-papillomavirus-related-anatomical-sites-in-the-united-states-objective-methods-results-and-conclusions/345697.png","ImageObject",300,407,{"name":92,"@type":93},"River Wang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What question does the study address about higher-order multiple primary cancers?","Question",{"text":112,"@type":113},"It characterizes the burden and patterns of higher-order (≥3 primaries) MPCs after cancers at HPV-related sites and evaluates persistent cross-site risk over long latency periods.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the study conducted and what data were used?",{"text":117,"@type":113},"A population-based retrospective cohort analyzed US SEER-8, SEER-17, and SEER-21 registry data from 1975 to 2022 to assess incidence, distribution, latency-specific standardized incidence ratios, and cross-site associations.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the study find about risk persistence and cross-site associations?",{"text":121,"@type":113},"Higher-order MPC risk was significantly elevated for most HPV-related sites and persisted for at least 10 years. The study also observed bidirectional cross-site associations, including anus-to-tonsil and tongue-to-vulva, across latency intervals of 10+ years.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},345697,1790147939,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":46,"preview_page_count":19,"preview_urls":144},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","Preventive Medicine Reports 68 (2026) 103517  \nContents lists available at ScienceDirect  \nPreventive Medicine Reports  \njournal [homepage:](homepage: www.elsevier.com/locate/pmedr)[ www.elsevier.com/locate/pmedr](homepage: www.elsevier.com/locate/pmedr)  \n| Higher-order multiple primary cancers and persistent cross-site risk across human papillomavirus-related anatomical sites in the United States: a population-based Surveillance, Epidemiology, and End Results study\u003Cbr>Tessho Maruyamaa,*, Makoto Kaneko b,c\u003Cbr>a Comprehensive Health Professions Education Center, The University of the Ryukyus Hospital, 1076 Kiyuna, Ginowan, Okinawa 901-2725, Japan b Department of Health Data Science, Yokohama City University, 22-2, Seto, Kanazawa-ku, Yokohama, Kanagawa 236-0027, Japan\u003Cbr>c Sagamihara Endowed Chair in Comprehensive Community Medicine, Kitasato University, 1-15-1, Kitazato, Minami-ku, Sagamihara-shi, Kanagawa 252-0373, Japan |  |  |\n| --- | --- | --- |\n| A R T I C L E I N F O |  | A B S T R A C T |\n| Keywords:\u003Cbr>Human papillomavirus Multiple primary cancers SEER\u003Cbr>Standardized incidence ratios |  | Objective: Survivors of cancers at human papillomavirus (HPV)-related sites are at increased risk of subsequent malignancies, but the burden and patterns of higher-order (≥3 primaries) multiple primary cancers (MPCs) and long-term cross-site risk patterns remain poorly understood. This study characterized these patterns and evaluated implications for cancer prevention and early detection.\u003Cbr>Methods: This population-based retrospective cohort study analyzed data from the United States Surveillance, Epidemiology, and End Results (SEER)-8, SEER-17, and SEER-21 registries from 1975 to 2022. We evaluated the incidence and distribution of MPCs as well as latency-specific standardized incidence ratios and cross-site associations across HPV-related sites.\u003Cbr>Results: Among 15.9 million cancer cases, 2.8 million (17.6%) were MPCs. Higher-order MPCs accounted for 4.1%–4.6% of diagnoses. Most HPV-related sites showed significantly elevated risk of higher-order MPCs, and the risk of MPCs persisted for ≥10 years of latency. Bidirectional cross-site associations included anus-to-tonsil and tongue-to-vulva associations at latency intervals of ≥10 years.\u003Cbr>Conclusions: Higher-order MPCs represent a substantial and underrecognized component of overall cancer burden. Survivors of cancers at HPV-related sites carry persistent, long-term cross-site risks. Current organspecific follow-up strategies may be insufficient and suggest the need for more integrated, long-term surveillance and prevention strategies in this population. |\n\n1. Introduction  \nMultiple primary cancers (MPCs) refer to the occurrence of two or more biologically distinct primary malignancies in the same individual (Sung et al., 2020; Wang et al., 2024; Zhang et al., 2024), excluding recurrence or metastasis, according to the criteria proposed by Warren and Gates and later refined by Moertel (Warren and Gates, 1932; Moertel et al., 1961). The incidence of MPCs is increasing, posing a growing challenge in cancer survivorship (Vogt et al., 2017; Tanaka et al., 2021), and opportunities for prevention and early detection in high-risk survivors remain incompletely defined.  \nPatients with cancers arising at human papillomavirus (HPV)-related  \nanatomical sites carry an increased risk of developing subsequent primary cancers. This pattern may partly reflect shared etiologic mechanisms, including possible HPV-related carcinogenesis in various sites in the body. Many of these sites are also accessible to clinical examination, offering opportunities for earlier detection (Dahlstrom et al., 2021; Malag´on et al., 2024; Suk et al., 2018).  \nPrior Surveillance, Epidemiology, and End Results (SEER)-based studies have primarily focused on second primary cancers (Suk et al., 2018) and have not adequately addressed higher-order MPCs (i.e., ≥3 primary cancers) or long-term cross-site risk patterns (Alm","cbCaipMVBzYeUrVO","https://ap.wps.com/l/cbCaipMVBzYeUrVO","pdf",3385777,"English","# Introduction\n## Multiple primary cancers and clinical relevance\n## HPV-related anatomical sites and gaps in SEER research\n# Methods\n## Data sources and study design\n## Risk and cross-site association assessments\n# Results\n## Incidence and distribution of higher-order MPCs\n## Latency-specific and bidirectional cross-site associations\n# Conclusions\n## Implications for integrated surveillance and prevention","[{\"question\":\"What question does the study address about higher-order multiple primary cancers?\",\"answer\":\"It characterizes the burden and patterns of higher-order (≥3 primaries) MPCs after cancers at HPV-related sites and evaluates persistent cross-site risk over long latency periods.\"},{\"question\":\"How was the study conducted and what data were used?\",\"answer\":\"A population-based retrospective cohort analyzed US SEER-8, SEER-17, and SEER-21 registry data from 1975 to 2022 to assess incidence, distribution, latency-specific standardized incidence ratios, and cross-site associations.\"},{\"question\":\"What did the study find about risk persistence and cross-site associations?\",\"answer\":\"Higher-order MPC risk was significantly elevated for most HPV-related sites and persisted for at least 10 years. The study also observed bidirectional cross-site associations, including anus-to-tonsil and tongue-to-vulva, across latency intervals of 10+ years.\"}]","Higher-order multiple primary cancers and persistent cross-site risk across human papillomavirus-related anatomical sites in the United States - Objective, Methods, Results and Conclusions | PDF",1790058638,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/275c423a700fdd93c25c44ee7852c189.webp",983,1310,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e7009921b9af343f6f52507315e5722d.webp",982,1309,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f5fb4152f5db7b101a2fed0047ec5147.webp",981,1308,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2b53741653e4e4403d879fc1f4d2dc7d.webp",980,1306]